Release Therapeutics Secures CHF 3.3 Million in Seed Funding
06 août 2024 04h00 HE
|
Release Therapeutics SA
Release Therapeutics Secures CHF 3.3 Million in Seed Funding following first preclinical results in metachromatic leukodystrophy.